Division of Paediatric Medicine, Paediatric Outcomes Research Team, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Division of Nephrology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
JAMA Pediatr. 2015 May;169(5):445-51. doi: 10.1001/jamapediatrics.2014.3809.
Use of hypotonic intravenous fluids for maintenance requirements is associated with increased risk of hyponatremia that results in morbidity and mortality in children. Clinical trial data comparing isotonic and hypotonic maintenance fluids in nonsurgical hospitalized pediatric patients outside intensive care units are lacking.
To compare isotonic (sodium chloride, 0.9%, and dextrose, 5%) with hypotonic (sodium chloride, 0.45%, and dextrose, 5%) intravenous maintenance fluids in a hospitalized general pediatric population.
DESIGN, SETTING, AND PARTICIPANTS: In this double-blind randomized clinical trial,we recruited 110 children admitted to a general pediatric unit of a tertiary care children's hospital from March 1, 2008, through August 31, 2012 (age range, 1 month to 18 years), with normal baseline serum sodium levels who were anticipated to require intravenous maintenance fluids for 48 hours or longer (intent-to-treat analyses). Children with diagnoses that required specific fluid tonicity and volumes were excluded.
Patients were randomized to receive isotonic or hypotonic intravenous fluid at maintenance rates for 48 hours.
The primary outcome was mean serum sodium level at 48 hours. The secondary outcomes were mean sodium level at 24 hours, hyponatremia and hypernatremia, weight gain, hypertension, and edema. Confounding variables were included in multiple regression models. Post hoc analyses included change from baseline sodium level at 24 and 48 hours and subgroup analysis of children with primary respiratory diagnosis.
Of 110 enrolled patients, 54 received isotonic fluids and 56 received hypotonic fluids. The mean (SD) sodium level at 48 hours was 139.9 (2.7) mEq/L in the isotonic group and 139.6 (2.6) mEq/L in the hypotonic group (95% CI of the difference, -0.94 to 1.74 mEq/L; P = .60). Two patients in the hypotonic group developed hyponatremia, 1 in each group developed hypernatremia, 2 in each group developed hypertension, and 2 in the isotonic group developed edema. Mean (SD) change from baseline to 48-hour sodium level was +1.3 (2.9) vs -0.12 (2.8) mEq/L, respectively (absolute difference, 1.4 mEq/L; 95% CI of the difference, -0.01 to 2.8 mEq/L; P = .05).
Our study results support the notion that isotonic maintenance fluid administration is safe in general pediatric patients and may result in fewer cases of hyponatremia.
clinicaltrials.gov Identifier: NCT00632775.
维持所需的低张静脉输液与导致发病率和死亡率的低钠血症风险增加有关。在非重症监护病房的住院儿科患者中,缺乏比较等张和低张维持液的临床试验数据。
比较等张(氯化钠 0.9%,葡萄糖 5%)与低张(氯化钠 0.45%,葡萄糖 5%)静脉维持液在住院普通儿科人群中的应用。
设计、地点和参与者:这是一项双盲随机临床试验,我们招募了 2008 年 3 月 1 日至 2012 年 8 月 31 日期间入住一家三级儿童医院普通儿科病房的 110 名儿童(年龄 1 个月至 18 岁),他们的基线血清钠水平正常,预计需要静脉维持液 48 小时或更长时间(意向治疗分析)。排除了需要特定液体张力和体积的诊断。
患者被随机分配接受等张或低张静脉输液,以维持 48 小时。
主要结局为 48 小时时的平均血清钠水平。次要结局包括 24 小时时的平均钠水平、低钠血症和高钠血症、体重增加、高血压和水肿。在多元回归模型中纳入了混杂变量。事后分析包括 24 小时和 48 小时时与基线钠水平的变化,以及主要呼吸诊断儿童的亚组分析。
在 110 名入组患者中,54 名接受等张液体,56 名接受低张液体。等张组 48 小时时的平均(标准差)钠水平为 139.9(2.7)mEq/L,低张组为 139.6(2.6)mEq/L(差异的 95%置信区间,-0.94 至 1.74 mEq/L;P=0.60)。低张组有 2 例患者出现低钠血症,等张组各有 1 例出现高钠血症,各有 2 例出现高血压,等张组有 2 例出现水肿。与 48 小时钠水平相比,从基线到 48 小时的平均(标准差)变化分别为+1.3(2.9)vs -0.12(2.8)mEq/L(绝对差值,1.4 mEq/L;95%置信区间的差值,0.01 至 2.8 mEq/L;P=0.05)。
我们的研究结果支持这样的观点,即在普通儿科患者中,给予等张维持液是安全的,并且可能导致更少的低钠血症病例。
clinicaltrials.gov 标识符:NCT00632775。